Researchers at Martin Luther University Halle-Wittenberg (MLU) have developed a promising new substance for targeting ...

Investing in Innovation Africa (i3) has announced three deals that directly connect African healthtech startups with global ...

The "Drug Discount Cards Market - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The ...

Investing in Innovation Africa (i3) held its 3rd flagship Access to Markets (A2M) event, a two-day gathering designed to ...

As Canadians live longer, healthier lives, more are choosing to take on occasional or part-time work to supplement their ...

Surge in cases of new variant H3N2 flu in UK and around the world ...

PCCA, a leading supplier of pharmaceutical ingredients, announced today the U.S. Pharmacopeia (USP) has verified SuspendIt® — ...

PCCA, a leading supplier of pharmaceutical ingredients, announced today the U.S. Pharmacopeia (USP) has verified SuspendIt(R) -- adding to its growing family of proprietary compounding bases that have ...

While Americans pay as much as $120,000 a year for treatments that cost $25,000 in Europe, drug companies and PBMs pocket massive margins. SHARx is exposing the myth of "unsafe importation" and ...

By designing a squaric acid amide that binds a new site on ATP synthase, researchers created PRP020, a potential therapy for ...

The line is underground closer to downtown, but in Scarborough it’s a frozen block of ice. As usual, downtown gets the cream, the suburbs get the transit dregs. Just look at how the TTC allowed the ...

Canada’s new HIV guidelines aim to expand access but overlook realities of Indigenous communities facing disproportionate ...